CRO concept sector strengthens, Chengda Pharmaceutical leads in gains

2026-03-27 22:15:22

March 27 news: As of 14:35, the CRO concept sector is strengthening. Zhaoyan New Drug has hit the daily limit. Shares such as Chengda Pharmaceuticals, Hait Biotech, Dezhan Health, and Wisdom Medical are among the top gainers.

Statement: The market involves risks; investment requires caution. This article is automatically published based on third-party databases and does not represent the views of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there are any discrepancies, please refer to the actual announcements. If you have any questions, please contact [email protected].

A massive amount of information and precise analysis—right on the Sina Finance app

责任编辑：小浪快报

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes